Aisling Capital V, LP 13D and 13G filings for Spruce Biosciences, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-06 4:15 pm Purchase | 2023-12-31 | 13G | Spruce Biosciences, Inc. SPRB | Aisling Capital V, LP | 1,205,511 3.000% | 1,205,511 (New Position) | Filing |